# Lamotrigine 25 mg Chewable Tablets, Non-Fasting

> **NCT00838136** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lamotrigine 25 mg Chewable Tablets
- **DRUG:** Lamictal® 25 mg Chewable Tablets

## Key facts

- **NCT ID:** NCT00838136
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2002-03
- **Final completion:** 2002-03
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00838136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00838136, "Lamotrigine 25 mg Chewable Tablets, Non-Fasting". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00838136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*